MIT-Led Team Receives $38 Million for Wearable Sepsis and Heart Failure Monitor

An MIT-led team received up to $38 million from U.S. ARPA-H to develop a noninvasive, wearable chip-based patch. This device aims to continuously monitor biomarkers in interstitial fluid for early detection of heart failure and sepsis. Powered by body heat, the patch will use on-chip AI to translate data into actionable clinical information, potentially enabling earlier intervention and shifting care from reactive treatment.